IRIS-COV – Market Release of a Portable Device for COVID-19 at the Point-of-Care; a Global Diagnostics Approach

IRIS-COV proposes a solution based on a patented portable device with isothermal LAMP amplification and real-time, quantitative, colourimetric detection that has proven 97.4 % sensitive and 100 % specific for SARS-CoV-2 in samples.
The project will validate and certify the portable device for COVID-19 and flu detection directly in crude samples and at the point of care, aiming towards its global uptake.

Details

Status:

  • inactive

Research Focus:

  • Medicine and Health

Project Coordination:

No results found.

Partners:

University College London Hospitals NHS Foundation Trust, United Kingdom
Institut National De La Sante Et De La Recherche Medicale, France
Biopix Dna Technology Anonymi Etairia, Greece
Universite Libre De Bruxelles, Belgium
Enzyquest Private Company, Greece
PKNM SOLUTIONS SARL, Switzerland

Countries:

Germany (Bavaria), South Africa

Funding Agency:

European Union (EU)

Funding Type:

H2020

Duration:

01/11/2020
– 30/04/2022

Budget:

2384878 EUR

URL: